Sort
50,496 grants matching “lung cancer”
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$1,402,170Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation
$1,401,672Tyler E Jacks · Massachusetts Institute Of Technology · P01 · FY2021 · CA
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation
$1,401,672Tyler E Jacks · Massachusetts Institute Of Technology · P01 · FY2017 · CA
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation
$1,401,672Tyler E Jacks · Massachusetts Institute Of Technology · P01 · FY2020 · CA
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation
$1,401,672Tyler E Jacks · Massachusetts Institute Of Technology · P01 · FY2018 · CA
Molecular Tumorigenesis of Bladder Cancer
$1,401,558Xue-Ru Wu · New York University School Of Medicine · P01 · FY2020 · CA
Computer Integrated Systems for Microscopy and Manipulation (CISMM)
$1,401,412Richard Superfine · Univ Of North Carolina Chapel Hill · P41 · FY2015 · EB
A POPULATION-BASED CASE-CONTROL STUDY OF LUNG CANCER IN APPALACHIAN KENTUCKY: THE ROLE OF ENVIRONMENTAL CARCINOGENS.
$1,400,930University Of Kentucky Research Foundation, The · · FY2011 · Department of the Army
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
$1,400,911James D Bearden · Spartanburg Regional Medical Center · U10 · FY2011 · CA
The connection of innate and adaptive anti-cancer immunity
$1,400,831John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Section on High Resolution Optical Imaging
$1,400,493Hari Shroff · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2014 · EB
Washington University Molecular Imaging Center
$1,400,000Washington University · P50 · FY2002 · CA
PLACENTAL CURATED RESEARCH DATASET
$1,399,986Lydia Rogers · Social And Scientific Systems, Inc. · N02 · FY2016 · HD
IMAGE AND MODEL BASED ANALYSIS OF LUNG DISEASE
$1,399,046University Of Iowa · R01 · FY2001 · HL
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS
$1,397,036Scott Powers · Cold Spring Harbor Laboratory · U01 · FY2014 · CA
Animal Model Development-CAPR infrastructure
$1,397,013Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
3/3: The Chicago Cancer HealthEquity Collaborative (ChicagoCHEC)
$1,396,714Marian L Fitzgibbon · University Of Illinois At Chicago · U54 · FY2022 · CA
Project 1: Characterization of the Antibody Response to SARS-CoV-2 in Lung Cancer Patients
$1,396,346Florian Krammer · Icahn School Of Medicine At Mount Sinai · U54 · FY2020 · CA
Tobacco Carcinogenesis and Chemoprevention
$1,395,941Institute For Cancer Prevention · P01 · FY2002 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,395,721Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Molecular Tumorigenesis of Bladder Cancer
$1,395,410Xue-Ru Wu · New York University School Of Medicine · P01 · FY2019 · CA
Tobacco Carcinogenesis and Chemoprevention
$1,395,357Institute For Cancer Prevention · P01 · FY2004 · CA
3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership
$1,394,613Upender Manne · University Of Alabama At Birmingham · U54 · FY2023 · CA
Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
$1,394,522Aaron Thomas Gerds · Case Western Reserve University · UG1 · FY2021 · CA
Washington University/ Siteman Cancer Center Lead Academic Site
$1,394,352Nancy L Bartlett · Washington University · U10 · FY2018 · CA